Earnings Feed
Start Free
Vir Biotechnology, Inc.·4

Jun 2, 7:31 PM ET

Sigal Charles Elliott 4

4 · Vir Biotechnology, Inc. · Filed Jun 2, 2025

Insider Transaction Report

Form 4
Period: 2025-05-30
Vir Biotechnology, Inc.VIR
Sigal Charles Elliott
Director
Transactions
  • Award

    Common Stock

    2025-05-30+8,000→ 31,806 total
  • Award

    Stock Option (Right to Buy)

    2025-05-30+16,000→ 16,000 total
    Exercise: $4.94From: 2026-05-30Exp: 2035-05-29→ Common Stock (16,000 underlying)
Holdings

  • Common Stock

    (indirect: By LLC)
    10,000
Footnotes (4)
  • [F1]Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • [F2]The RSUs will vest in full on May 30, 2026.
  • [F3]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F4]The shares subject to the stock option will vest and become exercisable in full on May 30, 2026.

Documents

3 files